Global Rapid Oral Fluid Screening Device Market – Industry Trends and Forecast to 2028

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Buy Now Buy Now Inquire Before Buying Inquire Before Free Sample Report Free Sample Report

Global Rapid Oral Fluid Screening Device Market – Industry Trends and Forecast to 2028

  • Medical Devices
  • Upcoming Report
  • Nov 2021
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Rapid Oral Fluid Screening Device Market

Market Size in USD Billion

CAGR :  % Diagram

Diagram Forecast Period
2021 –2028
Diagram Market Size (Base Year)
USD 6,867.15 Million
Diagram Market Size (Forecast Year)
USD 5,485,064.27 Million
Diagram CAGR
%
Diagram Major Markets Players
  • Abbott
  • Thermo Fisher Scientific
  • Drägerwerk
  • Laboratory Corporation of America Holdings
  • Quest Diagnostics orporated

Global Rapid Oral Fluid Screening Device Market, By Drug Type (Alcohol, Marijuana, Opioids, Cocaine, Amphetamine, Methamphetamine, Benzodiazepines and Others), Product (1- Panel Saliva Drug Test Kit, 4- Panel Saliva Drug Test Kits, 5- Panel Saliva Drug Test Kits, 6- Panel Saliva Drug Test Kits, 10- Panel Saliva Drug Test Kits and 12- Panel Saliva Drug Test Kits), By Form (Cassettes, Swabs and Strips), By Application (Criminal Justice Testing, Workplace Testing and Disease Testing), By End User (Hospitals, Diagnostic Laboratories, Forensic Laboratories, Private Employers, Home Care Settings and Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028.

Rapid Oral Fluid Screening Device Market

Market Analysis and Insights : Global Rapid Oral Fluid Screening Device Market

Data Bridge Market Research analyses that the rapid oral fluid screening device market will exhibit a CAGR of around 14.54% for the forecast period of 2021-2028. Rising prevalence of oral disorders, increased focus on research and development proficiencies in regards to medical devices and on the adoption of advanced healthcare technologies, growing awareness amongst the people regarding the benefits of rapid drug screening and rising expenditure for the development of healthcare infrastructure especially in the developing economies are the major factors attributable to the growth of rapid oral fluid screening device market. Therefore, the rapid oral fluid screening device market value, which was USD 5,485,064.27 million by 2028 from USD 6,867.15 million in 2020.

Rapid oral fluid screening devices provide a wide range of screening abilities. Rapid oral fluid screening devices are the medical devices that are used for the identification of drugs to process them through clinical trials until the selection of a candidate product is made.

Upsurge in the consumption of illegal narcotics, drugs and alcohol is one of the major factors fostering the growth of the market. Growth in the need for drug and alcohol testing is another market growth determinant. Stringent regulations put into place for mandatory drug and alcohol testing, growing application by physicians, independent healthcare providers, and hospital-based laboratories and rising medical tourism are other important factors that will further generate lucrative market growth opportunities.

However, improper and unfavourable reimbursement scenario in the developing and underdeveloped economies will derail the market growth rate. Also, high costs associated with research and development proficiencies will further pose challenges for the market. Dearth of skilled professionals in the backward economies will also hamper the market growth rate.

This rapid oral fluid screening device market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on rapid oral fluid screening device market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Rapid Oral Fluid Screening Device Market Scope and Market Size

The rapid oral fluid screening device market is segmented on the basis of drug type, product, form, application and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

  • On the basis of drug type, the rapid oral fluid screening device market is segmented into alcohol, marijuana, opioids, cocaine, amphetamine, methamphetamine, benzodiazepines and others.
  • On the basis of product, the rapid oral fluid screening device market is segmented into 1- panel saliva drug test kits, 4- panel saliva drug test kits, 5- panel saliva drug test kits, 6- panel saliva drug test kits, 10- panel saliva drug test kits and 12- panel saliva drug test kits.
  • On the basis of form, the rapid oral fluid screening device market is segmented into cassettes, swabs and strips.
  • Based on application, the rapid oral fluid screening device market is segmented into criminal justice testing, workplace testing and disease testing.

The end user segment of rapid oral fluid screening device market is segmented into hospitals, diagnostic laboratories, forensic laboratories, private employers, home care settings and others.

Rapid Oral Fluid Screening Device Market Country Level Analysis

The rapid oral fluid screening device market is analysed and market size insights and trends are provided by country, drug type, product, form, application and end user as referenced above.

The countries covered in the rapid oral fluid screening device market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the rapid oral fluid screening device market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is because of the increasing funding for research and development activities and ever-increasing instances of drug abuse and alcoholism. Asia-Pacific on the other hand is projected to exhibit the highest growth rate during the forecast period owing to the growing cases of illicit drug usage.

The country section of the rapid oral fluid screening device market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure growth Installed base and New Technology Penetration

The rapid oral fluid screening device market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for digital health technologies market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the rapid oral fluid screening device market. The data is available for historic period 2010 to 2019.

Competitive Landscape and Rapid Oral Fluid Screening Device Market Share Analysis

The rapid oral fluid screening device market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to rapid oral fluid screening device market.

The major players covered in the rapid oral fluid screening device market report are Abbott., Thermo Fisher Scientific Inc., Drägerwerk AG & Co. KGaA, Laboratory Corporation of America Holdings., Quest Diagnostics Incorporated., OraSure Technologies, Inc., Omega Laboratories, Inc., F. Hoffmann-La Roche Ltd, Shimadzu Corporation, Oranoxis, Premier Biotech, Inc., UCP Biosciences, Inc., SCREEN ITALIA Srl, Securetec., MEDACX Ltd., AccuBioTech Co., Ltd., Premier Biotech, Inc., Psychemedics Corporation and American Bio Medica Corporation among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

Research Methodology

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Customization Available

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The market is segmented based on , By Drug Type (Alcohol, Marijuana, Opioids, Cocaine, Amphetamine, Methamphetamine, Benzodiazepines and Others), Product (1- Panel Saliva Drug Test Kit, 4- Panel Saliva Drug Test Kits, 5- Panel Saliva Drug Test Kits, 6- Panel Saliva Drug Test Kits, 10- Panel Saliva Drug Test Kits and 12- Panel Saliva Drug Test Kits), By Form (Cassettes, Swabs and Strips), By Application (Criminal Justice Testing, Workplace Testing and Disease Testing), By End User (Hospitals, Diagnostic Laboratories, Forensic Laboratories, Private Employers, Home Care Settings and Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028. .
The Global Rapid Oral Fluid Screening Device Market size was valued at USD 6867.15 USD Million in 2020.
The Global Rapid Oral Fluid Screening Device Market is projected to grow at a CAGR of 15.54% during the forecast period of 2021 to 2028.
The major players operating in the market include Abbott, Thermo Fisher Scientific, Drägerwerk, Laboratory Corporation of America Holdings, Quest Diagnostics orporated, OraSure Technologies, Omega Laboratories, F. Hoffmann La Roche Ltd, Shimadzu Corporation, Oranoxis, Premier Biotech, UCP Biosciences, SCREEN ITALIA Srl, Securetec, MEDACX , AccuBioTech Co., Psychemedics Corporation, American Bio Medica Corporation.